» Articles » PMID: 37649636

Current Opinions on the Relationship Between CMTM Family and Hepatocellular Carcinoma

Overview
Date 2023 Aug 31
PMID 37649636
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is a typically malignant tumor in the digestive system. The mortality of HCC ranks third place in the world, second only to lung cancer and colorectal cancer. For the characteristics of high invasiveness, high metastasis, high recurrence rate as well as short survival time, HCC treatment has always been difficult in clinical practice. Many causes have contributed to the appearance of these features, including insidious onset, high degree of malignancy, lack of effective early molecular diagnostic markers, and disease prediction models. The human chemokine-like factor superfamily (CMTMs) is a new gene family consisting of CKLF and CMTM1-CMTM8. CMTMs have a marvel domain which can activate and chemotaxis immune cells. Many studies have reported that CMTMs are involved in the regulation of cell growth and development, and play an important role in the malignant progression of the immune system and reproductive system, especially in the development of tumors. In this review, we summarized the structure and function of the human CMTMs, the relationship between its family members and HCC, the prognostic value, potential functions, and mechanisms in HCC. CMTMs could provide a new diagnostic and therapeutic target in clinical practice for patients with HCC.

Citing Articles

Galactose-Induced Cataracts in Rats: A Machine Learning Analysis.

Al-Mashhadani A, Gong Q, Shehaj F, Zhou L Int J Med Sci. 2025; 22(5):1138-1149.

PMID: 40027191 PMC: 11866541. DOI: 10.7150/ijms.103892.


CMTM4 inhibits gastric tumorigenesis and metastasis.

Han X, Fu W, Sun Q, Ning J, Matsas S, de Melo F J Gastrointest Oncol. 2024; 15(4):1431-1445.

PMID: 39279978 PMC: 11399846. DOI: 10.21037/jgo-24-466.


Prognostic significance of RKIP, TGM2, and CMTM4 expression in oral squamous cell carcinoma.

Luo T, Xu T, Ou Y, Ci H, Sun J Medicine (Baltimore). 2024; 103(7):e37278.

PMID: 38363884 PMC: 10869054. DOI: 10.1097/MD.0000000000037278.

References
1.
Li H, Guo X, Shao L, Plate M, Mo X, Wang Y . CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway. BMB Rep. 2010; 43(3):182-7. DOI: 10.5483/bmbrep.2010.43.3.182. View

2.
Huang Z, Li P, Yang P, Hou X, Yang Y, Xu X . Overexpression of CMTM7 inhibits cell growth and migration in liver cancer. Kaohsiung J Med Sci. 2019; 35(6):332-340. DOI: 10.1002/kjm2.12058. View

3.
Chen Z, Cui N, Zhao J, Wu J, Ma F, Li C . Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances. Eur J Histochem. 2021; 65(1). PMC: 7856825. DOI: 10.4081/ejh.2021.3173. View

4.
Chen S, Hu Q, Chen H, Zhang F, Duan L, Wang B . Identification of Serum CMTM2 as a Potential Biomarker for HBV-Related Disorders. Dis Markers. 2020; 2020:2032056. PMC: 7568142. DOI: 10.1155/2020/2032056. View

5.
Cai X, Deng J, Ming Q, Cai H, Chen Z . Chemokine-like factor 1: A promising therapeutic target in human diseases. Exp Biol Med (Maywood). 2020; 245(16):1518-1528. PMC: 7553088. DOI: 10.1177/1535370220945225. View